Poland· PL-100223079
Spirytus salicylowy APTEO MED
A medicinal product containing spiritus salicylatus, registered in Poland by Synoptis Pharma Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Spiritus salicylatus
- Manufacturer
- Synoptis Pharma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990765546
- gtin05909990765553
- gtin05909990765560
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a844b662-391c-4c15-8e37-8d2b3b32352a GET /v1/drugs/a844b662-391c-4c15-8e37-8d2b3b32352a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór na skórę",
"source": "urpl",
"strength": "2%",
"packaging": "05909990765546 ¦ OTC ¦ Skasowane ¦ 56474\n1 op. 50 g\n05909990765553 ¦ OTC ¦ Skasowane ¦ 56475\n1 op. 90 g\n05909990765560 ¦ OTC ¦ 56476\n1 op. 100 g",
"substance": "Spiritus salicylatus 2 g",
"common_name": "Spiritus salicylatus",
"pl_product_id": "100223079",
"pozwolenie_nr": "16526",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about spiritus salicylatus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.